Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026
November 4, 2026
The latest from Geron.
Company news, financial updates, scientific presentations, and events as we advance treatments for people living with blood cancer.
You are now leaving the Geron Corporation website.
You will now be redirected to the requested website. Please confirm that you want to proceed.